Calendar Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Equities

688192

CNE1000055W8

End-of-day quote Shanghai S.E. 23:00:00 29/04/2024 BST 5-day change 1st Jan Change
45.05 CNY -0.29% Intraday chart for Dizal (Jiangsu) Pharmaceutical Co., Ltd. +19.56% -5.85%

Chart calendar Dizal (Jiangsu) Pharmaceutical Co., Ltd.

db67b0b6eeed.S0xeK7GSbKqGgIyQd9H8dTNC4cDFkecxzyW_cPBR3QM.cgg4E-n6J5ir783yQp-NRgEakILo9LJVrWHFRrknqTYmGxJqydwPy9zDvA~00b3944d7c3d71faf5c88babf68d4f73

Upcoming events on Dizal (Jiangsu) Pharmaceutical Co., Ltd.

01/06/2024 22:30 American Society of Clinical Oncology Annual Meeting - Abstract No : 8513
03/06/2024 19:30 American Society of Clinical Oncology Annual Meeting - Abstract No : 8563
22/08/2024 Q2 2024 Earnings Release (Projected)
27/10/2024 Q3 2024 Earnings Release (Projected)
23/02/2025 Q4 2024 Earnings Release (Projected)
24/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Dizal (Jiangsu) Pharmaceutical Co., Ltd.

29/04/2024 Q4 2023 Earnings Release
28/04/2024 Q1 2024 Earnings Release
27/10/2023 Q3 2023 Earnings Release
29/08/2023 Q2 2023 Earnings Release
06/06/2023 15:45 American Society of Clinical Oncology Conference - Abstract #7503
06/06/2023 15:45 American Society of Clinical Oncology Conference - Abstract #9002
04/06/2023 14:00 American Society of Clinical Oncology Conference - Abstract #9103
04/06/2023 14:00 American Society of Clinical Oncology Conference - Abstract #9073
28/04/2023 Q1 2023 Earnings Release
23/03/2023 Q4 2022 Earnings Release
28/10/2022 Q3 2022 Earnings Release
04/09/2022 European Society for Medical Oncology Meeting
25/08/2022 Interim 2022 Earnings Release
12/06/2022 10:30 European Hematology Association Meeting - Abstract #S218
06/06/2022 19:00 American Society of Clinical Oncology Meeting - Abstract #9015
06/06/2022 14:00 American Society of Clinical Oncology Meeting - Abstract #9015
06/06/2022 14:00 American Society of Clinical Oncology Meeting - Abstract #1038
04/06/2022 14:00 American Society of Clinical Oncology Meeting - Abstract #7563
02/06/2022 American Society of Clinical Oncology Meeting - Abstract #e15106
27/04/2022 Q1 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023
Net sales
Million CNY
Released
Forecast
Spread
0,00


10,3
11,0
-6.5%
0,00
0,00
-
91,3
108
-15.47%
EBITDA
Million CNY
Released
Forecast
Spread
0,00


0,00
0,00
-
-692
-690
-0.35%
-1 060
-884
-19.93%
EBIT
Million CNY
Released
Forecast
Spread
0,00


-670
-637
-5.16%
-736
-722
-1.9%
-1 108
-989
-11.96%
Earnings before Tax (EBT)
Million CNY
Released
Forecast
Spread
0,00


-670
-637
-5.16%
-736
-722
-1.87%
-1 108
-989
-11.96%
Net income
Million CNY
Released
Forecast
Spread
-587


-670
-637
-5.16%
-736
-722
-1.91%
-1 108
-990
-11.93%
EPS
CNY
Released
Forecast
Spread
-1,63


-1,86
-1,59
-16.98%
-1,82
-1,78
-2.25%
-2,72
-2,42
-12.24%
Announcement Date22/11/2125/02/2227/02/2324/02/24

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688192 Stock
  4. Calendar Dizal (Jiangsu) Pharmaceutical Co., Ltd.